WORK Medical Technology Group Ltd

Aktienanalyse zu WORK Medical Technology Group Ltd (WOK)

$0.945

+0.026 (+2.76%)Zum Schluss

Loading chart…
Hoch
0.983
Eröffnung
0.961
Volumengewichteter Durchschnittskurs
0.95
Volumen
26.79K
Marktkap.
—
Tief
0.930
Umsatz
25.52K
EV/EBITDA, TTM
0.00

WORK Medical Technology Group Ltd is a holding company mainly engaged in the research, development, manufacturing, and sales of medical devices. The Company's products include Class I disposable medical devices, Class II disposable medical devices, other medical devices, and medical innovative devices and equipment. The Class I disposable medical devices mainly include medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets and guedel airways. The Class II disposable medical devices mainly include disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kit, oxygen face masks, heat and moisture exchanger filter (HMEF), and nasal oxygen cannulas. Other medical devices mainly include KN95 masks and filtering half masks. The medical innovative devices and equipment mainly include visualized prostatic dilatation catheter. The Company distributes its products within the domestic market and to overseas markets.

www.workmedtech.com

KI-Analyse of WORK Medical Technology Group Ltd (WOK)

Verkaufen

Given the current price of 0.95, the RSI of 28.448 indicates the stock is oversold, but the forward P/E of 0 and a staggering year-to-date change of -99.59% suggest significant underlying issues. The main risk is the high debt-to-equity ratio of 100.75%, which raises concerns about financial stability.

Bewertungskennzahlen

Das aktuelle erwartete KGV von WORK Medical Technology Group Ltd (WOK) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von 0.00.

Erwartetes KGV

Stark unterbewertet
5J-Durchschnitt P/E
0.00
Aktuelles P/E
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes EV/EBITDA

Stark unterbewertet
5J-Durchschnitt EV/EBITDA
0.00
Aktuelles EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Erwartetes KUV

Stark unterbewertet
5J-Durchschnitt P/S
0.00
Aktuelles P/S
0.00
Überbewertet
0.00
Unterbewertet
0.00

Alphio-AI-Kursszenarien für WOK

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%WOK

$0.95

Szenariopreis

B

Basis

Basis · 50%WOK

$0.86

Szenariopreis

B

Bärisch

Bärisch · 25%WOK

$0.80

Szenariopreis

Event-Zeitleiste

2026-06-17 (ET)

20:00:00

Work Medical Technology Group Ltd Trading Halted, News Pending

2026-05-13 (ET)

09:40:00

Work Medical Technology Group Ltd Trading Halted

2026-05-11 (ET)

09:40:00

WORK Medical Enters Strategic Cooperation Agreement with Novabioplus

2025-12-29 (ET)

09:40:00

WORK Medical Technology Signs Exclusive Distribution Agreement with Shanghai Benke

09:10:00

WORK Medical Technology Subsidiary Receives Approval for AI Blood Cell Analyzer

News

WOK FAQ – beantwortet von Alphio AI

WORK Medical Technology Group Ltd is a holding company mainly engaged in the research, development, manufacturing, and sales of medical devices. The Company's products include Class I disposable medical devices, Class II disposable medical devices, other medical devices, and medical innovative devices and equipment. The Class I disposable medical devices mainly include medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets and guedel airways. The Class II disposable medical devices mainly include disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kit, oxygen face masks, heat and moisture exchanger filter (HMEF), and nasal oxygen cannulas. Other medical devices mainly include KN95 masks and filtering half masks. The medical innovative devices and equipment mainly include visualized prostatic dilatation catheter. The Company distributes its products within the domestic market and to overseas markets. It operates in the Healthcare sector.

Given the current price of 0.95, the RSI of 28.448 indicates the stock is oversold, but the forward P/E of 0 and a staggering year-to-date change of -99.59% suggest significant underlying issues. The main risk is the high debt-to-equity ratio of 100.75%, which raises concerns about financial stability.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln